Jan 22, 2022 6:49 AM
BACK TO TOP
KSE100
45,018.28
192.31
(0.43%)
ALLSHR
30,878.62
128.59
(0.42%)
KSE30
17,747.58
81.79
(0.46%)
KMI30
73,001.88
177.24
(0.24%)
BKTi
13,340.89
45.93
(0.35%)
OGTi
11,919.03
-29.59
(-0.25%)
KMIALLSHR
22,211.76
46.47
(0.21%)
UPP9
12,123.86
65.42
(0.54%)
NITPGI
9,509.05
42.98
(0.45%)
NBPPGI
11,228.61
43.07
(0.39%)
MZNPI
9,811.51
15.81
(0.16%)
JSMF
10,085.66
36.95
(0.37%)
ACI
10,056.68
25.59
(0.26%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.33.86
0.35
(1.04%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Jan 21, 2022 4:39 PM
REG
FUT
ODL
Open
33.79
High
34.20
Low
33.70
Volume
367,500
CIRCUIT BREAKER
31.00 — 36.02
DAY RANGE
33.70 — 34.20
52-WEEK RANGE
29.00 — 55.06
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
33.51
VAR
12.00
HAIRCUT
15.00
P/E Ratio (TTM) **
6.70
1-Year Change *
1.04%
YTD Change *
-5.31%

No record found

Open
33.80
High
34.10
Low
33.75
Close
33.75
Change
0.72%
LDCP
33.51
Volume
1,867
Total Trades
37
CIRCUIT BREAKER
30.16 — 36.86
DAY RANGE
33.75 — 34.10
Ask Price
34.00
Ask Volume
331
Bid Price
33.62
Bid Volume
50
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Mr. Rizwan SheikhCEO
Mr. Nadeem AmjadChairman
Mr. Muhammad RiazCompany Secretary
ADDRESS

Corporate Office: 588-Q Block, Johar Town, Lahore

WEBSITE

www.citipharma.com.pk

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
7,735,696.23
Shares
228,461,200
Free Float
79,961,420
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 29, 2021Financial Results for the first quarter ended September 30, 2021 View   PDF
Oct 7, 2021Transmission of Annual Report for the year ended June 30, 2021 View   PDF
Sep 30, 2021Financial Results for the year ended June 30, 2021 View   PDF
DateTitleDocument
Dec 29, 2021Resolutions Passed in Annual General Meeting View   PDF
Oct 22, 2021Board Meeting View   
Oct 7, 2021Notice of Annual General Meeting View   PDF
Sep 23, 2021Board Meeting View   
Sep 13, 2021Decisions of Baord Meeting View   PDF
Aug 31, 2021Board Meeting View   
Aug 13, 2021Decisions of the Board Meeting View   PDF
Aug 6, 2021Board Meeting View   
Aug 6, 2021Board Meeting
REVOKED
View   
DateTitleDocument
Dec 31, 2021Material Information View   
Nov 25, 2021Credit of Final Cash Dividend View   
Nov 22, 2021Material Information View   
Nov 18, 2021Credit of Bonus Share Certificates View   PDF
Nov 1, 2021Transmission of Quarterly Report for the period September 30, 2021 View   PDF
Sep 16, 2021Material Information View   PDF
Aug 6, 2021Change of Director View   
Jul 27, 2021Change of Director View   
Jul 14, 2021Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2021202020192018
Sales5,795,4043,527,6252,607,0282,003,334
Profit after Taxation351,768143,41627,804116,866
EPS4.6431.876.1825.97
Q1 2022Q3 2021Q2 2021Q1 2021
Sales1,990,9534,015,415
Profit after Taxation81,357252,436
EPS0.413.88
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2021202020192018
Gross Profit Margin (%)13.4712.3912.6913.12
Net Profit Margin (%)6.074.071.075.83
EPS Growth (%)(85.44)415.70(76.20)37.70
PEG(0.09)

Payouts

DateFinancial ResultsDetailsBook Closure
September 30, 2021 9:32 PM30/06/2021(YR) 15% (D) - 10% (B) 21/10/2021 - 28/10/2021

Financial Reports